Navigating the Manufacturing Process and Ensuring the Quality of Regenerative Medicine Therapies Proceedings of a Workshop (2017) / Chapter Skim
Currently Skimming:
Appendix B: Speaker Biographical Sketches
Appendix B: Speaker Biographical Sketches
Pages 89-96
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 89... ...
Robert Deans, Ph.D., is the chief technology officer at BlueRock Therapeutics, a biotechnology company creating innovative cell therapeutics by harnessing gene editing tools and pluripotent stem cell biology. Prior to joining BlueRock, he was the chief scientific officer at Rubius Therapeutics, a red cell therapeutics platform company.
|
From page 90... ...
He then directed the Cell Processing Laboratory at The University of Texas MD Anderson Cancer Center until 1999, when he joined the Center for Cell and Gene Therapy at Baylor College of Medicine in Houston. He was involved in the development of standards for the collection processing and transplantation of hematopoietic stem cells for the Foundation for the Accreditation of Cell Therapy (FACT)
|
From page 91... ...
Following the sale of AutoSyringe, Inc., he founded DEKA Research & Development Corporation to develop internally generated inventions as well as to provide research and development for major corporate clients. Mr. Kamen led DEKA's development of the HomeChoice™ peritoneal dialysis system for Baxter International Inc.
|
From page 92... ...
She currently serves as the principal investigator for production assistance for cellular therapies–cell processing facilities to perform pre-clinical cell therapy product development in collaboration with the National Heart, Lung, and Blood Institute and other Production Assistance for Cellular Therapies Centers and as core laboratory technical director for the Moffitt Cancer Center Support Grant.
|
From page 93... ...
McBurney has conducted basic and clinical research and managed research groups for drug discovery, personalized medicine, and clinical decision support systems at medical schools, research institutes, biopharmaceutical companies, and nonprofit organizations in Australia, the United Kingdom, and the United States.
|
From page 94... ...
Rodney Rietze, Ph.D., began his graduate training in regenerative medicine in the laboratory of Samuel Weiss (director, Hotchkiss Brain Institute) , who is credited with the discovery of adult neural stem cells (NSCs)
|
From page 95... ...
and principal investigator of the Neural Stem Cell and Aging Laboratory, Dr. Rietze continued to investigate the biology of adult NSCs, cumulating with the discovery of the essential role that growth hormone receptor signaling plays in stimulating endogenous precursors and reversing age-related cognitive decline.
|
From page 96... ...
Tsokas leads Johnson & Johnson cross-sector efforts to enhance awareness and connectivity for the development of processes that enable assessing, partnering, and developing safe and effective advanced therapies globally. In addition, she represents global regulatory affairs on the Johnson & Johnson First in Human Committee.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.